ResistanceBio
PrivateLast Round
Series A
Jan 31, 2024
Est. Valuation
$2.14M
Total Funding Raised
$13.05M
Company Overview
ResistanceBio is a biotechnology company that develops therapeutics and predictive models to combat treatment-resistant cancer. The company spun out of Viosera Therapeutics in 2021, pivoting from antimicrobial resistance to oncology. ResistanceBio's proprietary platform, the ResCu™ system, is a cell culture-based discovery system that models how tumors respond to treatments and develop resistance. This system aims to identify novel drug targets and biomarkers to create multi-targeted therapies that can preemptively counter cancer's adaptive resistance mechanisms, ultimately aiming to provide more durable cures. The company is venture-backed, having raised a $12.8M Series A round in January 2024.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResistanceBio Comps
Public and private peers based on sector, stage, and business model.
ResistanceBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 31, 2024 | ||||
| VC Round | Mar 29, 2021 | ||||
| Seed | Mar 19, 2019 | ||||
| Grant | Sep 11, 2017 |
ResistanceBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centennial Investors | Series A |
| NFX | Series A |
| Cantos Ventures | Series A |
| Awah Ventures | Series A |
| Brightstone Venture Capital | Series A |
| Y Combinator | Series A, Seed |
| Alumni Ventures | Series A |
ResistanceBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ResistanceBio's valuation, stock price, and market status.
